If you are a clinical trial professional who has never included EEG (electroencephalography) in trials, an Austrian company now wants to convince you of the merits of EEG. The Siesta Group, a Vienna based company providing services for clinical trials, is currently running the “EEG Awareness Weeks” between Jan 7 and Mar 31, 2013. The ongoing free webinar’s main topic is “What EEG can do for a trial”. On top of the online sessions a free feasibility analysis concerning efforts and costs of including EEG in an early or late phase trial is offered to all participants.
The Siesta Group is a leader for computer supported services in clinical trials and research involving sleep and/or EEG analysis and thus a prime partner for pharmaceutical and device industry. The free webinar is directed toward all clinical trial professionals who work on the development of CNS-active drugs and plan a new early or late phase clinical trial.
Interested persons can mark a date for the following webinars by contacting firstname.lastname@example.org:
- Thursday, Feb 14, 2013, 4pm GMT (11am EST)
- Friday, Mar 15, 2013, 3pm GMT (11am EDT)
- Main EEG paradigms and endpoints
- Brain disorders and drug action as seen in the EEG
- The key-lock principle
- PD/PK modeling with EEG
- EEG topographies
- How The Siesta Group can support clinical trial EEG
Every participant will be entitled to receive a free feasibility and cost analysis about including EEG in a mock or real sample trial. Including EEG can be much more cost-effective than expected.